Skip to main content
Erschienen in: World Journal of Surgical Oncology 1/2018

Open Access 01.12.2018 | Research

Laparoscopic and endoscopic cooperative surgery for intra-mucosal gastric carcinoma adjacent to the ulcer scars

verfasst von: Masahiko Aoki, Satoshi Tokioka, Ken Narabayashi, Akitoshi Hakoda, Yosuke Inoue, Naoki Yorifuji, Yoshihide Chino, Isao Sato, Yutaro Egashira, Toshihisa Takeuchi, Kazuhide Higuchi

Erschienen in: World Journal of Surgical Oncology | Ausgabe 1/2018

Abstract

Background

Laparoscopic and endoscopic cooperative surgery (LECS) was performed for the local resection of gastrointestinal stromal tumors (GIST). LECS enables less resection of the lesion area and preserves function. Furthermore, LECS can be safely performed and independent of tumor location. However, LECS is not usually used for cases involving gastric carcinoma because it may seed tumor cells into the peritoneal cavity when the gastric wall is perforated. Here, we report seven cases of LECS for intra-mucosal gastric carcinoma, which were difficult to carry out by endoscopic submucosal dissection (ESD) because of ulcer scars.

Methods

We performed LECS (classical LECS and inverted LECS) in seven cases of intra-mucosal gastric carcinoma. All cases had ulcer scars beside the tumor. LECS was chosen because ESD was thought to be difficult because of the ulcer scars. We only selected cases in which the patients did not prefer gastrectomy and endoscopic examination was indicative of intra-mucosal gastric carcinoma.

Results

In all cases, LECS was performed without severe complications including postoperative stenosis. Histopathology findings proved that the tumors were intra-mucosal carcinoma and had been resected completely. Furthermore, there were ulcer scars (Ul IIIs-IVs) beside the tumor. Currently, dissemination and recurrence have not been apparent.

Conclusions

LECS for intra-mucosal gastric carcinoma is an efficient procedure, but strict observation is necessary because of the possibility of peritoneal dissemination. Results suggest that LECS is likely to be effective for cases involving intra-mucosal gastric carcinoma that are difficult to treat by ESD due to ulcer scars.

Background

Laparoscopic and endoscopic cooperative surgery (LECS) is routinely performed for the local resection of gastrointestinal stromal tumors (GIST) [14]. This procedure has been on the national insurance list since February 2014 in Japan. LECS is an endoscopic dissection of the mucosal to submucosal layers followed by laparoscopic seromuscular resection and is independent of tumor location. Incision lines are determined, and a mucosal to submucosal incision is performed endoscopically, while the seromuscular layer is incised and the incision line is laparoscopically closed.
However, LECS is not usually used in cases involving gastric carcinoma because it may seed tumor cells into the peritoneal cavity if the gastric wall is perforated.
In general, endoscopic submucosal dissection (ESD) is applied for early gastric cancer [5, 6]. Endoscopic resection is less invasive than conventional surgery [7]. In our cases, we performed LECS for early gastric carcinoma because ulcer scars were located close by; consequently, ESD was likely to be very difficult to perform, leading to an expectation of a more complicated procedure and a broader range of dissection owing to the scarring. Furthermore, reports have shown that the larger the lesion, the higher the incidence of bleeding and perforation [8]. Also, while stricture is known to occur after ESD [9, 10], LECS results in no postoperative transformation of the remaining stomach [1]. We choose LECS to prevent these complications, and only selected cases involving patients who did not prefer gastrectomy and in which endoscopic examination was indicative of intra-mucosal gastric carcinoma. We performed LECS after fully explaining the procedure to the patients and with the permission of the local ethics committee. In the beginning, we performed classical LECS in four cases. Peritoneal dissemination has not yet been reported in these cases. However, to prevent the seeding of tumor cells into the peritoneal cavity when the gastric wall was perforated, we have performed inverted LECS [11] since February 2016.

Methods

We retrospectively assessed seven cases at the First Towakai Hospital. Patients were 66- to 91-year-old male. We choose the cases where endoscopic examination was indicative of intra-mucosal gastric carcinoma adjacent to the ulcer scars, so ESD was thought to be difficult. Also, the patients preferred to avoid a gastrectomy. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national), with the Declaration of Helsinki of 1964 and later versions, and also with the permission of the First Towakai Hospital IRB/ethics committee. Informed consent or a substitute for it was obtained from all patients for their being included in the study. Consent, for the publication of the case reports and any additional related information, was taken from the patients involved in the study. From January 2014 to February 2017, we performed classical LECS in four cases and inverted LECS in three cases of intra-mucosal gastric carcinoma. The surgical procedure first involved processing the serosal side laparoscopically around the tumor. We then used endoscopy to determine the incision line and entire circumference of the mucosal incision using an IT-2 knife. We used a needle knife to perforate the gastric wall and then used the IT-2 knife to make a full-thickness incision. After the incision using the IT-2 knife, we inserted an ultrasonically activated device into the perforation hole and accomplished the incision. A specimen was taken out from the mouth side or naval incision. The incision line was then closed using a laparoscopic hand-suturing technique. When a specimen was taken from the ventral side, we quickly recovered it and placed it into a specimen bag as soon as possible.
In the case of inverted LECS, after determining the incision line endoscopically, the gastric wall was lifted up circumferentially outside the incision line by several stitches resembling a crown (Fig. 1). This procedure made the tumor turn towards the intra-gastric cavity when the gastric wall was perforated.

Results

Mean patient age for the classical and inverted LECS cases was 78.8 ± 9.3 years and 79.0 ± 3.6 years, respectively. Mean operation time was 181.5 ± 37.9 min and 192.3 ± 51.9 min, for the two types of surgery, with a mean blood loss of 11.3 ± 5.4 ml and 11.0 ± 6.5 ml, for classical and inverted LECS, respectively. Mean length of postoperative hospital stay was 16.3 ± 2.1 days and 17 ± 5.1 days, respectively (Table 1). In all cases, there were no postoperative complications including stenosis. At the time of writing, dissemination and recurrence have not been recognized during follow-up (Table 2). Histopathology findings proved that tumors were intra-mucosal carcinomas and had been resected completely. Furthermore, there were ulcer scars (Ul IIIs-IVs) beside the tumors. In here, we listed one representative case of each LECS procedure.
Table 1
Characteristics and operative data for cases involving laparoscopic and endoscopic cooperative surgery (LECS)
  
Classical (n = 4)
Inverted (n = 3)
Sex (male/female)
 
4/0
3/0
Age (years)
 
78.8 ± 9.3
79.0 ± 3.6
Location of tumor
   
 
Angle, lesser curvature
2
2
 
Body, posterior
1
 
 
Body, lesser curvature
1
 
 
Body, greater curvature
 
1
Tumor size (mm)
 
14.5 ± 3.6 (10–20)
11.7 ± 6.2 (5–20)
Operation time (min)
 
181.5 ± 37.9
192.3 ± 51.9
Intraoperative blood loss (ml)
 
11.3 ± 5.4
11.0 ± 6.5
Conversion to open surgery
 
0
0
Postoperative complications
 
0
0
Gastric fullness
 
0
0
Anastomotic leakage
 
0
0
Anastomotic stenosis
 
0
0
Anastomotic bleeding
 
0
0
Postoperative hospital stay (days)
 
16.3 ± 2.1
17.0 ± 5.1
Table 2
Follow-up and passage after laparoscopic and endoscopic cooperative surgery (LECS)
Case
Age (years)
Sex
Tumor size (mm)
Classical/inverted
Follow-up after LECS (image)
Passage after LECS
1
91
Male
20
Classical
Endoscopy; 3, 9, 20 months
CT; 3 months
No dissemination and recurrence, 42 months after LECS (alive)
2
66
Male
10
Classical
Endoscopy; 6, 18, 20 months
CT; 16 months
No dissemination and recurrence, 35 months after LECS (alive)
3
75
Male
13
Classical
Endoscopy; 3 months CT; 1, 21 months
No dissemination and recurrence, died of pneumonia 24 months after LECS
4
83
Male
15
Classical
Endoscopy; 15, 27 months
CT;
11, 17, 23, 29
months
No dissemination and recurrence, 33 months after LECS (alive)
5
82
Male
20
Inverted
Endoscopy; 3, 6, 11 months
CT; 7, 12 months
No dissemination and recurrence, 18 months after LECS (alive)
6
74
Male
10
Inverted
Endoscopy; 3 months
CT; 2, 4, 7 months
No dissemination and recurrence, 14 months after LECS (alive)
7
81
Male
5
Inverted
Endoscopy; 3 months
No dissemination and recurrence, 6 months after LECS (alive)
LECS laparoscopic and endoscopic cooperative surgery, CT computed tomography
Case 1 is a 91-year-old male. Tumor size was 20 mm and located at the angle of the lesser curvature. Ulcer scar was on the anal side of the tumor. Classical LECS was performed without complication. Histopathology findings proved that the tumor was intra-mucosal carcinoma and was resected completely. Ulcer scars (Ul IIIs-IVs) were evident beside the tumor (Fig. 2).
Case 2 is an 82-year-old male. Tumor size was 20 mm and located at the angle of the lesser curvature. Ulcer scar was located on the posterior side of the tumor. Inverted LECS was performed without complication. Histopathology findings proved that the tumor was intra-mucosal carcinoma and was resected completely. Ulcer scars (Ul IIIs-IVs) were evident beside the tumor.

Discussion

Intra-mucosal gastric cancer carries a low risk of lymph node metastasis [12]. ESD is indicated as a standard treatment (absolute indication or expanded indication) [13]. In our cases, the tumors were predicted as intra-mucosal gastric carcinomas, as a result of endoscopic examination. However, it was expected that the procedure would be complicated if ESD was performed. The greater the degree of submucosal fibrosis, the longer an ESD procedure can last and the higher the frequency of complications such as perforation and immediate bleeding [14]. In order to carry out the dissection safely with an accurately cut line, and to avoid excessive resection of the gastric wall, we choose to use LECS for our cases. LECS was successfully applied in cases of intra-mucosal gastric carcinomas which would have been difficult to treat with ESD due to ulcer scars. In all cases, there was no postoperative stricture, which may occur if ESD was performed. In a previous study, LECS was also performed for lateral-spreading mucosal gastric cancer which would have been difficult to treat with ESD because of the high incidence of complications and the long surgical time required for ESD [11].
Previous reports have shown that gastric perforation during endoscopic resection for gastric carcinoma does not lead to peritoneal dissemination, even in the long term [15]. However, we need to try not to seed tumor cells into the peritoneal cavity to prevent peritoneal dissemination when the gastric wall is perforated during the LECS procedure. Thus, in the inverted LECS procedure, the gastric wall is lifted up circumferentially outside of the incision line by several stitches [11]. This procedure enables us to prevent contact between the tumor and visceral tissue and prevents gastric juice from falling into the peritoneal cavity. Other techniques such as “CLEAN-NET” or “NEWS” [1618] also prevent peritoneal dissemination by allowing non-exposure gastric wall resection. However, the mucosal layer shifts significantly from the seromuscular layer during surgery, so that they are not applied for tumor located at the EGJ or pyloric ring, and also the muscle layer and seromuscular layer may be incorrectly dissected. On the other hand, LECS can be applied for any tumor location [19]. Thus, LECS is likely to be effective in these cases, although strict observation is necessary for LECS in cases of intra-mucosal gastric carcinoma.
Due to ulcer scars located in the vicinity of a tumor, sometimes it is difficult to diagnose whether the tumor represents intra-mucosal carcinoma or submucosal infiltration carcinoma. On the other hand, sentinel node mapping for early gastric cancer has been reported [20, 21]; detection rate and the accuracy of prediction of lymph node metastasis based on sentinel status are of high value. In the future, combining sentinel node mapping technology and the adoption of LECS for early gastric carcinoma will be very important in dealing with cases involving intra-mucosal carcinoma that would be difficult to treat by ESD due to ulcer scars or location, and in cases of submucosal carcinoma without lymph node metastasis.

Conclusion

LECS for the stomach is an efficient, safe procedure that can preserve function. LECS for intra-mucosal gastric carcinoma is an efficient procedure, but strict observation is necessary because of the possibility of peritoneal dissemination. Results suggest that LECS is likely to be effective for cases involving intra-mucosal gastric carcinoma that are difficult to treat by ESD due to ulcer scars.

Acknowledgements

Not applicable

Funding

None

Availability of data and materials

Not applicable
The study was approved by the ethics committee of the First Towakai Hospital.
The study was undertaken with patient’s consent.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat Hiki N, Yamamoto Y, Fukunaga T, Yamaguchi T, Nunobe S, Tokunaga M, Miki A, Ohyama S, Seto S. Laparoscopic and endoscopic cooperative surgery for gastrointestinal stromal tumor dissection. Surg Endosc. 2008;22:1729–35.CrossRefPubMed Hiki N, Yamamoto Y, Fukunaga T, Yamaguchi T, Nunobe S, Tokunaga M, Miki A, Ohyama S, Seto S. Laparoscopic and endoscopic cooperative surgery for gastrointestinal stromal tumor dissection. Surg Endosc. 2008;22:1729–35.CrossRefPubMed
2.
Zurück zum Zitat Choi SM, Kim MC, Jung GJ, Kim HH, Kwon HC, Choi SR, Jang JS, Jeong JS. Laparoscopic wedge resection for gastric GIST: long-term follow-up results. Eur J Surg Oncol. 2007;33:444–7.CrossRefPubMed Choi SM, Kim MC, Jung GJ, Kim HH, Kwon HC, Choi SR, Jang JS, Jeong JS. Laparoscopic wedge resection for gastric GIST: long-term follow-up results. Eur J Surg Oncol. 2007;33:444–7.CrossRefPubMed
3.
Zurück zum Zitat Kawahira H, Hayashi H, Natsume T, Akai T, Uesato M, Horibe D, Mori M, Hanari N, Aoyama H, Nabeya Y, Shuto K, Matsubara H. Surgical advantages of gastric SMTs by laparoscopy and endoscopy cooperative surgery. Hepato-Gastroenterology. 2012;59:415–7.PubMed Kawahira H, Hayashi H, Natsume T, Akai T, Uesato M, Horibe D, Mori M, Hanari N, Aoyama H, Nabeya Y, Shuto K, Matsubara H. Surgical advantages of gastric SMTs by laparoscopy and endoscopy cooperative surgery. Hepato-Gastroenterology. 2012;59:415–7.PubMed
4.
Zurück zum Zitat Hoteya S, Haruta S, Shinohara H, Yamada A, Furuhata T, Yamashita S, Kikuchi D, Mitani T, Ogawa O, Matsui A, Iizuka T, Udagawa H, Kaise M. Feasibility and safety of laparoscopic and endoscopic cooperative surgery for gastric submucosal tumors, including esophagogastric junction tumors. Dig Endosc. 2014;26:538–44.CrossRefPubMed Hoteya S, Haruta S, Shinohara H, Yamada A, Furuhata T, Yamashita S, Kikuchi D, Mitani T, Ogawa O, Matsui A, Iizuka T, Udagawa H, Kaise M. Feasibility and safety of laparoscopic and endoscopic cooperative surgery for gastric submucosal tumors, including esophagogastric junction tumors. Dig Endosc. 2014;26:538–44.CrossRefPubMed
5.
Zurück zum Zitat Gotoda T. A large endoscopic resection by endoscopic submucosal dissection procedure for early gastric cancer. Clin Gastroenterol Hepatol. 2005;3:S71–3.CrossRefPubMed Gotoda T. A large endoscopic resection by endoscopic submucosal dissection procedure for early gastric cancer. Clin Gastroenterol Hepatol. 2005;3:S71–3.CrossRefPubMed
6.
Zurück zum Zitat Fujishiro M, Yahagi N, Nakamura M, Kakushima N, Kodashima S, Ono S, Kobayashi K, Hashimoto T, Yamamichi N, Tateishi A, Shimizu Y, Oka M, Ogura K, Kawabe T, Ichinose M, Omata M. Successful outcomes of a novel endoscopic treatment for GI tumors: endoscopic submucosal dissection with a mixture of high-molecular-weight hyaluronic acid, glycerin, and sugar. Gastrointest Endosc. 2006;63:243–9.CrossRefPubMed Fujishiro M, Yahagi N, Nakamura M, Kakushima N, Kodashima S, Ono S, Kobayashi K, Hashimoto T, Yamamichi N, Tateishi A, Shimizu Y, Oka M, Ogura K, Kawabe T, Ichinose M, Omata M. Successful outcomes of a novel endoscopic treatment for GI tumors: endoscopic submucosal dissection with a mixture of high-molecular-weight hyaluronic acid, glycerin, and sugar. Gastrointest Endosc. 2006;63:243–9.CrossRefPubMed
7.
Zurück zum Zitat Ono H, Kondo H, Gotoda T, Shirao K, Yamaguchi H, Saito D, Hosokawa K, Shimoda T, Yoshida S. Endoscopic mucosal resection for treatment of early gastric cancer. Gut. 2001;48:225–9.CrossRefPubMedPubMedCentral Ono H, Kondo H, Gotoda T, Shirao K, Yamaguchi H, Saito D, Hosokawa K, Shimoda T, Yoshida S. Endoscopic mucosal resection for treatment of early gastric cancer. Gut. 2001;48:225–9.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Oda I, Gotoda T, Hamanaka H, Eguchi T, Saito Y, Matsuda T, Bhandari P, Emura F, Saito D, Ono H. Endoscopic submucosal dissection for early gastric cancer: technical feasibility, operation time and complications from a large consecutive series. Dig Endosc. 2005;17:54–8.CrossRef Oda I, Gotoda T, Hamanaka H, Eguchi T, Saito Y, Matsuda T, Bhandari P, Emura F, Saito D, Ono H. Endoscopic submucosal dissection for early gastric cancer: technical feasibility, operation time and complications from a large consecutive series. Dig Endosc. 2005;17:54–8.CrossRef
9.
Zurück zum Zitat Iizuka H, Kakizaki S, Sohara N, Onozato Y, Ishihara H, Okamura S, Itoh H, Mori M. Stricture after endoscopic submucosal dissection for early gastric cancers and adenomas. Dig Endosc. 2010;22:282–8. Iizuka H, Kakizaki S, Sohara N, Onozato Y, Ishihara H, Okamura S, Itoh H, Mori M. Stricture after endoscopic submucosal dissection for early gastric cancers and adenomas. Dig Endosc. 2010;22:282–8.
10.
Zurück zum Zitat Ohara Y, Toyonaga T, Tanabe A, Takihara H, Baba S, Inoue T, Ono W, Kawara F, Tanaka S, Azuma T. Endoscopic antralplasty for severe gastric stasis after wide endoscopic submucosal dissection in the antrum. Clin J Gastroenterol. 2016;9:63–7.CrossRefPubMedPubMedCentral Ohara Y, Toyonaga T, Tanabe A, Takihara H, Baba S, Inoue T, Ono W, Kawara F, Tanaka S, Azuma T. Endoscopic antralplasty for severe gastric stasis after wide endoscopic submucosal dissection in the antrum. Clin J Gastroenterol. 2016;9:63–7.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Nunobe S, Hiki N, Gotoda T, Murao T, Haruma K, Matsumoto H, Hirai T, Tanimura S, Sano T, Yamaguchi T. Successful application of laparoscopic and endoscopic cooperative surgery (LECS) for a lateral-spreading mucosal gastric cancer. Gastric Cancer. 2012;15:338–42.CrossRefPubMed Nunobe S, Hiki N, Gotoda T, Murao T, Haruma K, Matsumoto H, Hirai T, Tanimura S, Sano T, Yamaguchi T. Successful application of laparoscopic and endoscopic cooperative surgery (LECS) for a lateral-spreading mucosal gastric cancer. Gastric Cancer. 2012;15:338–42.CrossRefPubMed
12.
Zurück zum Zitat Yamao T, Shirao K, Ono H, Kondo H, Saito D, Yamaguchi H, Sasako M, Sano T, Ochiai A, Yoshida S. Risk factors for lymph node metastasis from intramucosal gastric carcinoma. Cancer. 1996;77:602–6.CrossRefPubMed Yamao T, Shirao K, Ono H, Kondo H, Saito D, Yamaguchi H, Sasako M, Sano T, Ochiai A, Yoshida S. Risk factors for lymph node metastasis from intramucosal gastric carcinoma. Cancer. 1996;77:602–6.CrossRefPubMed
13.
Zurück zum Zitat Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20:1–19. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20:1–19.
14.
Zurück zum Zitat Jeong JY, Oh YH, Yu YH, Park HS, Lee HL, Eun CS, Han DS. Does submucosal fibrosis affect the results of endoscopic submucosal dissection of early gastric tumors? Gastrointest Endosc. 2012;76(1):59–66.CrossRefPubMed Jeong JY, Oh YH, Yu YH, Park HS, Lee HL, Eun CS, Han DS. Does submucosal fibrosis affect the results of endoscopic submucosal dissection of early gastric tumors? Gastrointest Endosc. 2012;76(1):59–66.CrossRefPubMed
15.
Zurück zum Zitat Ikehara H, Gotoda T, Ono H, Oda I, Saito D. Gastric perforation during endoscopic resection for gastric carcinoma and the risk of peritoneal dissemination. Br J Surg. 2007;94:992–5.CrossRefPubMed Ikehara H, Gotoda T, Ono H, Oda I, Saito D. Gastric perforation during endoscopic resection for gastric carcinoma and the risk of peritoneal dissemination. Br J Surg. 2007;94:992–5.CrossRefPubMed
16.
Zurück zum Zitat Inoue H, Ikeda H, Hosoya T, Yoshida A, Onimaru M, Suzuki M, Kudo S. Endoscopic mucosal resection, endoscopic submucosal dissection, and beyond: full-layer resection for gastric cancer with nonexposure technique (CLEAN-NET). Surg Oncol Clin N Am. 2012;21:129–40.CrossRefPubMed Inoue H, Ikeda H, Hosoya T, Yoshida A, Onimaru M, Suzuki M, Kudo S. Endoscopic mucosal resection, endoscopic submucosal dissection, and beyond: full-layer resection for gastric cancer with nonexposure technique (CLEAN-NET). Surg Oncol Clin N Am. 2012;21:129–40.CrossRefPubMed
17.
Zurück zum Zitat Goto O, Mitsui T, Fujishiro M, Wada I, Shimizu N, Seto Y, Koike K. New method of endoscopic full-thickness resection: a pilot study of non-exposed endoscopic wall-inversion surgery in an ex vivo porcine model. Gastric Cancer. 2011;14:183–7.CrossRefPubMed Goto O, Mitsui T, Fujishiro M, Wada I, Shimizu N, Seto Y, Koike K. New method of endoscopic full-thickness resection: a pilot study of non-exposed endoscopic wall-inversion surgery in an ex vivo porcine model. Gastric Cancer. 2011;14:183–7.CrossRefPubMed
18.
Zurück zum Zitat Mitsui T, Goto O, Shimizu N, Hatao F, Wada I, Niimi K, Asada I, Fujishiro M, Koike K, Seto Y. Novel technique for full-thickness resection of gastric malignancy: feasibility of nonexposed endoscopic wall-inversion surgery (news) in porcine models. Surg Laparosc Endosc Percutan Tech. 2013;23:e217–21.CrossRefPubMed Mitsui T, Goto O, Shimizu N, Hatao F, Wada I, Niimi K, Asada I, Fujishiro M, Koike K, Seto Y. Novel technique for full-thickness resection of gastric malignancy: feasibility of nonexposed endoscopic wall-inversion surgery (news) in porcine models. Surg Laparosc Endosc Percutan Tech. 2013;23:e217–21.CrossRefPubMed
19.
Zurück zum Zitat Hiki N, Nunobe S, Matsuda T, Hirasawa T, Yamamoto Y, Yamaguchi T. Laparoscopic and endoscopic cooperative surgery. Dig Endosc. 2015;27(2):197–204.CrossRefPubMed Hiki N, Nunobe S, Matsuda T, Hirasawa T, Yamamoto Y, Yamaguchi T. Laparoscopic and endoscopic cooperative surgery. Dig Endosc. 2015;27(2):197–204.CrossRefPubMed
20.
Zurück zum Zitat Takeuchi H, Kitagawa Y. New sentinel node mapping technologies for early gastric cancer. Ann Surg Oncol. 2013;20:522–32.CrossRefPubMed Takeuchi H, Kitagawa Y. New sentinel node mapping technologies for early gastric cancer. Ann Surg Oncol. 2013;20:522–32.CrossRefPubMed
21.
Zurück zum Zitat Kitagawa Y, Takeuchi H, Takagi Y, Natsugoe S, Terashima M, Murakami N, Fujimura T, Tsujimoto H, Hayashi H, Yoshimizu N, Takagane A, Mohri Y, Nabeshima K, Uenosono Y, Kinami S, Sakamoto J, Morita S, Aikou T, Miwa K, Kitajima M. Sentinel node mapping for gastric cancer: a prospective multicenter trial in Japan. J Clin Oncol. 2013;31(29):3704–10.CrossRefPubMed Kitagawa Y, Takeuchi H, Takagi Y, Natsugoe S, Terashima M, Murakami N, Fujimura T, Tsujimoto H, Hayashi H, Yoshimizu N, Takagane A, Mohri Y, Nabeshima K, Uenosono Y, Kinami S, Sakamoto J, Morita S, Aikou T, Miwa K, Kitajima M. Sentinel node mapping for gastric cancer: a prospective multicenter trial in Japan. J Clin Oncol. 2013;31(29):3704–10.CrossRefPubMed
Metadaten
Titel
Laparoscopic and endoscopic cooperative surgery for intra-mucosal gastric carcinoma adjacent to the ulcer scars
verfasst von
Masahiko Aoki
Satoshi Tokioka
Ken Narabayashi
Akitoshi Hakoda
Yosuke Inoue
Naoki Yorifuji
Yoshihide Chino
Isao Sato
Yutaro Egashira
Toshihisa Takeuchi
Kazuhide Higuchi
Publikationsdatum
01.12.2018
Verlag
BioMed Central
Erschienen in
World Journal of Surgical Oncology / Ausgabe 1/2018
Elektronische ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-018-1355-0

Weitere Artikel der Ausgabe 1/2018

World Journal of Surgical Oncology 1/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.